Remedium Lifecare Statistics

Total Valuation

Remedium Lifecare has a market cap or net worth of INR 2.10 billion. The enterprise value is 3.86 billion.

Market Cap	2.10B
Enterprise Value	3.86B

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Remedium Lifecare has 403.20 million shares outstanding. The number of shares has increased by 47.56% in one year.

Current Share Class	n/a
Shares Outstanding	403.20M
Shares Change (YoY)	+47.56%
Shares Change (QoQ)	+8.50%
Owned by Insiders (%)	63.40%
Owned by Institutions (%)	1.53%
Float	124.45M

Valuation Ratios

The trailing PE ratio is 12.86.

PE Ratio	12.86
Forward PE	n/a
PS Ratio	0.09
PB Ratio	5.04
P/TBV Ratio	4.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.66, with an EV/FCF ratio of -2.19.

EV / Earnings	16.03
EV / Sales	0.12
EV / EBITDA	15.66
EV / EBIT	15.69
EV / FCF	-2.19

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 3.95.

Current Ratio	1.02
Quick Ratio	0.47
Debt / Equity	3.95
Debt / EBITDA	7.36
Debt / FCF	-1.03
Interest Coverage	3.60

Financial Efficiency

Return on equity (ROE) is 70.88% and return on invested capital (ROIC) is 12.28%.

Return on Equity (ROE)	70.88%
Return on Assets (ROA)	0.76%
Return on Capital (ROIC)	12.28%
Revenue Per Employee	4.78B
Profits Per Employee	34.44M
Employee Count	7
Asset Turnover	1.65
Inventory Turnover	19.32

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-80.55%
50-Day Moving Average	6.18
200-Day Moving Average	15.26
Relative Strength Index (RSI)	32.92
Average Volume (20 Days)	739,021

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Remedium Lifecare had revenue of INR 33.45 billion and earned 241.05 million in profits. Earnings per share was 0.41.

Revenue	33.45B
Gross Profit	307.55M
Operating Income	246.24M
Pretax Income	375.07M
Net Income	241.05M
EBITDA	246.71M
EBIT	246.24M
Earnings Per Share (EPS)	0.41

Full Income Statement

Balance Sheet

The company has 51.13 million in cash and 1.81 billion in debt, giving a net cash position of -1.76 billion or -4.37 per share.

Cash & Cash Equivalents	51.13M
Total Debt	1.81B
Net Cash	-1.76B
Net Cash Per Share	-4.37
Equity (Book Value)	458.99M
Book Value Per Share	1.03
Working Capital	458.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.76 billion and capital expenditures 92,000, giving a free cash flow of -1.76 billion.

Operating Cash Flow	-1.76B
Capital Expenditures	92,000
Free Cash Flow	-1.76B
FCF Per Share	-4.38

Full Cash Flow Statement

Margins

Gross margin is 0.92%, with operating and profit margins of 0.74% and 0.72%.

Gross Margin	0.92%
Operating Margin	0.74%
Pretax Margin	1.12%
Profit Margin	0.72%
EBITDA Margin	0.74%
EBIT Margin	0.74%
FCF Margin	n/a

Dividends & Yields

Remedium Lifecare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.56%
Shareholder Yield	-47.56%
Earnings Yield	7.78%
FCF Yield	-83.98%

Stock Splits

The last stock split was on July 5, 2024. It was a forward split with a ratio of 4.

Last Split Date	Jul 5, 2024
Split Type	Forward
Split Ratio	4

Scores

Remedium Lifecare has an Altman Z-Score of 1.91. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.91
Piotroski F-Score	n/a